Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Comparison of Health Outcomes in Adolescent and Young Adults (AYA) Oncology Patients Treated at a Pediatric Versus Adult Institute

Amy Moskop, MD, Ke Yan, PhD, Sarah K. Dobrozsi, MD, Julie Panepinto, MDMSPH

Blood (2019) 134 (Supplement_1): 4743.

https://doi.org/10.1182/blood-2019-121616

Published: 2019

Journal Articles

Transplant Rates and Outcomes of Young Acute Myeloid Leukemia (AML) Patients with Intermediate and Poor Risk Disease Referred to a Coordinated Acute Leukemia and Hematopoietic Stem Cell Transplant (HSCT) Program

Melhem Solh, MD, Xu Zhang, PhD, Asad Bashey, MD PhD, Lawrence E Morris, MD, Zain Bashey, H. Kent Holland, MD, Scott R Solomon, MD

Blood (2018) 132 (Supplement 1): 4797.

https://doi.org/10.1182/blood-2018-99-119185

Published: 2018

Journal Articles

A Single Institution Comparison of Treatment Outcomes of Adolescent and Young Adult (AYA) Patients with Acute Myeloid Leukemia (AML) Treated in Pediatric and Adult Settings

Vaibhav Agrawal, MD MBA, Jordyn Griffin, MD, Andrew O'Brien, MD, Robert P. Nelson, Jr., MD, Jodi L. Skiles, MD, Heiko Konig, MD PhD

Blood (2018) 132 (Supplement 1): 5859.

https://doi.org/10.1182/blood-2018-99-114189

Published: 2018

Journal Articles

Outpatient Intensive Induction Chemotherapy for Acute Myeloid Leukemia and Advanced Myelodysplastic Syndrome

Frances Linzee Mabrey, MD, Kelda M Gardner, PA-C, Kathleen Shannon Dorcy, RN, PhD, Andrea Perdue, PA-C, Heather Smith, PA-C, Alicyn Marie Davis, ARNP, Cody Hammer, Donelle Rizzuto, RN, Sunny So, RN, Anna Rosen, Kim Quach, Bart L. Scott, MD, Paul C. Hendrie, MD PhD, Mary Beth M. Percival, MD, Roland B. Walter, MD PhD MS, Frederick R. Appelbaum, MD, Elihu H. Estey, MD, Pamela S. Becker, MD PhD

Blood (2017) 130 (Supplement 1): 3851.

https://doi.org/10.1182/blood.V130.Suppl_1.3851.3851

Published: 2017

Journal Articles

The Relationship Between Emotional Distress and Understanding of Prognosis in Patients with Acute Myeloid Leukemia (AML)

Nick Bloom, BA, MA, Thomas W. LeBlanc, MD MA

Blood (2016) 128 (22): 1237.

https://doi.org/10.1182/blood.V128.22.1237.1237

Published: 2016

Journal Articles

Impact of a Patient-Centered Support Program on Treatment Compliance Among Patients with Multiple Myeloma

Nicole Cross, BS, Dale Hanna, Dana Stafkey-Mailey, PharmD, PhD, Michael Eaddy, PharmD, PhD, Manasi Suryavanshi, MPH

Blood (2016) 128 (22): 2389.

https://doi.org/10.1182/blood.V128.22.2389.2389

Published: 2016

Journal Articles

Behavioral Patterns and the Role of Ethnicity in Patient Awareness of Multiple Myeloma and the Psychophysical Impact of Its Treatment

Pooja Advani, MBBS, Abhisek Swaika, MBBS, Denice D. Tsao-Wei, PhD, Ahsan Alamgir, Brian Chung, Christine Duran, Susan Groshen, PhD, Savrina Bola, Asher Chanan-Khan, MD, Sikander Ailawadhi, MD

Blood (2014) 124 (21): 2622.

https://doi.org/10.1182/blood.V124.21.2622.2622

Published: 2014

Journal Articles

Prognostic Understanding, Quality of Life, and Mood in Patients Undergoing Hematopoietic Stem Cell Transplantation

Areej El-Jawahri, MD, Lara Traeger, PhD, Kailyn Kuzmuk, B.A., Justin Eusebio, B.S., Harry Vandusen, B.S., Jennifer Shin, MD, Emily Gallagher, RN, Joseph Greer, PhD, William Pirl, MD, Vicki Jackson, MD, Karen K. Ballen, MD, Thomas R. Spitzer, MD, Timothy A. Graubert, MD, Steven L. McAfee, MD, Bimalangshu R. Dey, MD PhD, Yi-Bin Chen, MD, Jennifer S. Temel, MD

Blood (2014) 124 (21): 1296.

https://doi.org/10.1182/blood.V124.21.1296.1296

Published: 2014

Journal Articles

Impact of a Patient-Access Program with Integrated Distress Screening on Resource Utilization and Psychosocial Distress Levels in Patients with Multiple Myeloma

Victoria Kennedy, LCSW, Joanne S. Buzaglo, PhD, Sara Goldberger, LCSW-R

Blood (2014) 124 (21): 1319.

https://doi.org/10.1182/blood.V124.21.1319.1319

Published: 2014

Journal Articles

The Impact of a Pre-Existing Psychiatric Diagnoses on a Newly Diagnosed Acute Leukemia Patient's Emotional Functioning During Induction Chemotherapy as Measured by the Brief Symptom Inventory-18 (BSI-18).

Dawn Speckhart, Ph.D., Scott R. Solomon, MD, Asad Bashey, MD, PhD, Lawrence Morris JR, MD, Tina Berry, MS, H. Kent Holland, MD

Blood (2010) 116 (21): 1505.

https://doi.org/10.1182/blood.V116.21.1505.1505

Published: 2010

Journal Articles

Erythrocytapheresis in Sickle Cell Disease and Multi-Organ Failure in the Intensive Care Unit.

Shatha Y. Farhan, MD, Ileana Lopez_Plaza, MD

Blood (2009) 114 (22): 4627.

https://doi.org/10.1182/blood.V114.22.4627.4627

Published: 2009

Journal Articles

Quality of Life after High Dose Chemotherapy with Autologous Hematopoietic Progenitor Cell Support Long Term Follow-Up.

Marylou Nesbitt, APRN-BC, Kenneth A. Ault, MD, Fred Aronson, MD, Marjorie A. Boyd, MD, Delvyn Caedren Case, MD, Matthew Dugan, DO, Kurt Ebraham, MD, Jacqueline Hedlund, MD, Helen Ryan, MD, Kristiina Hyrkas, Ph.D

Blood (2007) 110 (11): 3331.

https://doi.org/10.1182/blood.V110.11.3331.3331

Published: 2007

Journal Articles

Infectious Morbidity and Hospitalization Requirements of Patients with Acute Myeloid Leukemia Receiving Intensive Outpatient Consolidation.

Stan Benke, MD, E. J. Bow, MD, B. Schacter, MD, J. Loughery, RN, P. Benjaminson, RN, M. D. Seftel, MD, M. Rubinger, MD

Blood (2004) 104 (11): 4524.

https://doi.org/10.1182/blood.V104.11.4524.4524

Published: 2004

Journal Articles

Psychosocial Screening for Bone Marrow Transplant Recipients.

Matt R. Wild, DClinPsy, Laura Meehan, RGN, Jane Laing, RGN, Anne Parker, MD

Blood (2004) 104 (11): 5025.

https://doi.org/10.1182/blood.V104.11.5025.5025

Published: 2004

NARROW

Comparison of Health Outcomes in Adolescent and Young Adults (AYA) Oncology Patients Treated at a Pediatric Versus Adult Institute

Transplant Rates and Outcomes of Young Acute Myeloid Leukemia (AML) Patients with Intermediate and Poor Risk Disease Referred to a Coordinated Acute Leukemia and Hematopoietic Stem Cell Transplant (HSCT) Program

A Single Institution Comparison of Treatment Outcomes of Adolescent and Young Adult (AYA) Patients with Acute Myeloid Leukemia (AML) Treated in Pediatric and Adult Settings

Outpatient Intensive Induction Chemotherapy for Acute Myeloid Leukemia and Advanced Myelodysplastic Syndrome

The Relationship Between Emotional Distress and Understanding of Prognosis in Patients with Acute Myeloid Leukemia (AML)

Impact of a Patient-Centered Support Program on Treatment Compliance Among Patients with Multiple Myeloma

Behavioral Patterns and the Role of Ethnicity in Patient Awareness of Multiple Myeloma and the Psychophysical Impact of Its Treatment

Prognostic Understanding, Quality of Life, and Mood in Patients Undergoing Hematopoietic Stem Cell Transplantation

Impact of a Patient-Access Program with Integrated Distress Screening on Resource Utilization and Psychosocial Distress Levels in Patients with Multiple Myeloma

The Impact of a Pre-Existing Psychiatric Diagnoses on a Newly Diagnosed Acute Leukemia Patient's Emotional Functioning During Induction Chemotherapy as Measured by the Brief Symptom Inventory-18 (BSI-18).

Erythrocytapheresis in Sickle Cell Disease and Multi-Organ Failure in the Intensive Care Unit.

Quality of Life after High Dose Chemotherapy with Autologous Hematopoietic Progenitor Cell Support Long Term Follow-Up.

Infectious Morbidity and Hospitalization Requirements of Patients with Acute Myeloid Leukemia Receiving Intensive Outpatient Consolidation.

Psychosocial Screening for Bone Marrow Transplant Recipients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only